Besivance Ophthalmic Solution
Formulated to alleviate bacterial conjunctivitis to support clear ocular tissues and target localised bacterial pathogens.
- Category
- Eye Care
- Active ingredient
- Besifloxacin
- Route
- Ocular use
- Form
- Ophthalmic Solution
- Strengths
- 5ml
Prescription and consultation requirements for Besivance Ophthalmic Solution vary by destination and are determined by the fulfilment partner.
Besivance Ophthalmic Solution details
- Condition
- Bacterial Conjunctivitis
- Alternative names
- besifloxacin
- Therapeutic class
- Fluoroquinolone
- Pharmacological class
- Fluoroquinolone Antibacterial
- Contraindications
- hypersensitivity to besifloxacin
- Minor side effects
- mild eye discomfort; transient blurred vision
- Moderate side effects
- conjunctival redness; mild pruritus; headache
- Serious side effects
- corneal ulceration, requires immediate medical attention
- Dosage forms
- Ophthalmic Solution
- Administration route
- Ocular use
- Supply category
- Prescription-only medicine (POM)
- Manufacturer
- Bausch & Lomb
- Onset Time
- 24–48 hours
- Duration
- 8 hours
- Storage instructions
- Store below 25°C.
- Age restrictions
- Approved for infants over one year, children, and adults.
Patient summary
formulated to alleviate bacterial conjunctivitis to support clear ocular tissues and target localised bacterial pathogens.
Mechanism of action
Inhibits essential DNA replication enzymes topoisomerase II and IV to stop bacterial growth on corneal surfaces.
Pregnancy and breastfeeding
TGA Category C: Minimal systemic exposure. Use if indicated. Breastfeeding: Consult a doctor.